New Member – Alejandro Gutierrez

New Member – Alejandro Gutierrez

The BSEL would like to welcome Alejandro De Janon Gutierrez to the lab!

 

Alejandro received his degree of chemical engineer at the National Technological University  (UTN), Buenos Aires, Argentina. During his final year of study and after obtaining his degree, he worked in process risk management consulting for oil, chemical, food and pharmaceutical companies. After being awarded with a Fulbright Scholarship, Alejandro continued his studies and obtained his Master in Biotechnology at Texas A&M. During his masters he worked on bioprocessing and downstream purification of proteins. His research on this field led him to an internship at Merck & Co. where he gained experience on monoclonal antibodies manufacturing.

 

After completing his masters, Alejandro came to Georgia Tech to pursue his PhD in Bioengineering. His research is focused on developing a 3D in vitro leukemia model, analyzing cancer metabolism to culture leukemic cells.

 

 

Publication Announcement – Cancer Immunology, Immunotherapy

Publication Announcement – Cancer Immunology, Immunotherapy

We are pleased to announce that our Dr. Panoskaltsis’ work on TGN1412-induced cytokine storm has been published in Cancer Immunology, Immunotherapy. The article entitled “Myelopoiesis of acute inflammation: lessons from TGN1412-induced cytokine storm” highlights TGN1412, a superagonist monoclonal antibody targeting CD28, which caused cytokine storm in six healthy volunteers in a first-in-man study in 2006. The TGN1412-induced cytokine storm offers unique insights into the pathogenesis of anemia of inflammation and offer immunological correlates and insights into the hematopoiesis of inflammation, aging, and BM failure disorders such as MDS..

http://link.springer.com/article/10.1007/s00262-020-02702-9 

Our Paper was selected by ACS as the Editors’ Choice

Our Paper was selected by ACS as the Editors’ Choice

The BSEL’s most recent paper has received the great honor of being chosen as the American Chemical Society’s Editors’ Choice! The article entitled “Linking Engineered Gene Circuit Kinetic Modeling to Cellulose Biosynthesis Prediction in Escherichia coli: Toward Bioprocessing of Microbial Cell Factories” was featured in Industrial & Engineering Chemistry Research in which we present a rational modeling approach linking the designed engineered gene circuit to bioprocess kinetics, whereby the engineered gene circuit model informs the formulation of product biosynthesis and is coupled to microbial growth. This kinetic model is a practical and complementary approach to systems and synthetic biology for the robust operation of microbial cell factory systems and their bioprocess applications. Read more here

Publication Announcement – CORDIS

Publication Announcement – CORDIS

We are pleased to announce that our lab’s BioBlood project has been selected for publication in the “Results in Brief” section of the European Commission’s CORDIS (Community Research and Development Information Service). The article entitled “Development of a Bio-Inspired Blood Factory for Personalized Healthcare” highlights our BioBlood platform which represents an engineered bio-inspired integrated experimental/modelling platform for normal and abnormal haematopoiesis. Our platform offers a dynamic, 3D perfusion bone marrow biomimicry in a bioreactor. It produces multiple cell types simultaneously and has the potential to be used for transfusion purposes or to discover personalized drug targets.

https://cordis.europa.eu/project/rcn/110516/brief/en?WT.mc_id=exp